MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2
about
The PI3K/Akt Pathway in Tumors of Endocrine TissuesmiRNA Influences in NRF2 Pathway Interactions within Cancer ModelsSignificance and therapeutic value of miRNAs in embryonal neural tumorsmiRNA and mammalian male germ cellsEpigenetic deregulation of microRNAs in rhabdomyosarcoma and neuroblastoma and translational perspectivesInhibition of neuroblastoma tumor growth by targeted delivery of microRNA-34a using anti-disialoganglioside GD2 coated nanoparticlesMicroRNA dysregulation in the spinal cord following traumatic injurySuppression of miR-184 in malignant gliomas upregulates SND1 and promotes tumor aggressivenessDownregulation of miR-101 in gastric cancer correlates with cyclooxygenase-2 overexpression and tumor growthAnalysis of circulating microRNAs in adrenocortical tumorsExpression of circulating miRNAs associated with lymphocyte differentiation and activation in CLL-another piece in the puzzle.Regulation of cancer aggressive features in melanoma cells by microRNAs.MicroRNA-184 downregulates nuclear receptor corepressor 2 in mouse spermatogenesis.A single-base substitution in the seed region of miR-184 causes EDICT syndrome.miRNA expression profiling of the murine TH-MYCN neuroblastoma model reveals similarities with human tumors and identifies novel candidate miRNAsFoxD3-regulated microRNA-137 suppresses tumour growth and metastasis in human hepatocellular carcinoma by targeting AKT2.MicroRNA-542-5p as a novel tumor suppressor in neuroblastomamiR-335 and miR-363 regulation of neuroblastoma tumorigenesis and metastasis.Syngeneic cardiac and bone marrow stromal cells display tissue-specific microRNA signatures and microRNA subsets restricted to diverse differentiation processesCandidate tumour suppressor CCDC19 regulates miR-184 direct targeting of C-Myc thereby suppressing cell growth in non-small cell lung cancers.Expression of microRNA-184 in keratinocytes represses argonaute 2.MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferationUnique microRNA-profiles in EGFR-mutated lung adenocarcinomas.Akt2 regulates metastatic potential in neuroblastoma.The miR-184 binding-site rs8126 T>C polymorphism in TNFAIP2 is associated with risk of gastric cancer.Efficacy of histone deacetylase and estrogen receptor inhibition in breast cancer cells due to concerted down regulation of AktSirt1 inhibits akt2-mediated porcine adipogenesis potentially by direct protein-protein interaction.microRNA-184 functions as tumor suppressor in renal cell carcinoma.Mir-184 post-transcriptionally regulates SOX7 expression and promotes cell proliferation in human hepatocellular carcinoma.MicroRNA-184 inhibits cell proliferation and invasion, and specifically targets TNFAIP2 in GliomaA functional variant at the miR-184 binding site in TNFAIP2 and risk of squamous cell carcinoma of the head and neckMicroRNA and DNA methylation alterations mediating retinoic acid induced neuroblastoma cell differentiation.Systems toxicology approaches enable mechanistic comparison of spontaneous and cigarette smoke-related lung tumor development in the A/J mouse model.MicroRNA profiling of the pubertal mouse mammary gland identifies miR-184 as a candidate breast tumour suppressor geneMiRNA-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF-β signalling pathway.Alterations in expression of specific microRNAs by combination of 4-HPR and EGCG inhibited growth of human malignant neuroblastoma cells.Deregulation of focal adhesion pathway mediated by miR-659-3p is implicated in bone marrow infiltration of stage M neuroblastoma patients.Identification and differential expression of microRNAs in the ovaries of pigs (Sus scrofa) with high and low litter sizes.Small RNA sequencing of cryopreserved semen from single bull revealed altered miRNAs and piRNAs expression between High- and Low-motile sperm populations.Modulation of neuroblastoma disease pathogenesis by an extensive network of epigenetically regulated microRNAs.
P2860
Q26770404-CA7DAACD-1E62-4165-AA1A-6C16F1AAF395Q26783311-88CAC7D0-91CC-446D-9E5D-ED40C001FD6EQ26827171-17F5D6FF-98E9-48B0-8F67-60F5BEE66222Q26992374-7433CFA3-4AD1-4C17-8F71-0219B2ADB2B2Q26999187-70DC0C91-21DB-4E4C-A2B9-874460452966Q27301841-369ECCCE-FB07-4351-A3EB-48EC564F5950Q27305161-086A7603-54A9-4D31-BDF9-90A4C939ECF1Q28247786-6F0F5F2A-1A19-43E7-8146-F6A718A0E90FQ28275778-92C3E557-C826-47F9-B6A5-581AE92E9E34Q28303947-9B8E2772-63B3-4570-A65A-D2943087764FQ33364071-6E94CEEC-3A4D-4CA1-A519-8CEC3FA830C6Q33889489-F80C47DB-DAAD-4BC9-81AA-5ADDABA2BE0BQ34053879-6BA45370-215B-4485-BC16-AAE0A1E62883Q34087435-7EE8C146-DA30-4DDC-A4EE-F7107FA518D0Q34099211-4C6FCE06-7F29-4094-93A1-6E10705F6CDEQ34104157-CEF35A03-E859-4962-B6D9-C1B6B243B492Q34163789-EC3D77E7-FAE9-4A3C-A3D5-C45D97605AEFQ34194661-28B1C4E8-9797-4AE4-960E-EF40F770B226Q34215130-C7933BDE-5B3F-4853-AF53-315C85D3297DQ34311253-ADC09C2D-3D4C-4409-BDBC-C1370698E3B4Q34346039-76CF930B-B63D-488A-9097-5F17F98F678EQ34506870-5C5A4CD0-5321-4911-9A4C-3A72B01D4A22Q34531091-6EED1B17-604D-49AA-968B-6FEAC79465E3Q34611459-FE62F9EA-4205-4906-9086-F2B25796F83CQ34749907-9724FB5B-7B9B-48AC-902E-07E965DBD084Q34852154-BD287838-13C2-488E-B046-1FE09AC1BFCDQ34949971-692E9487-C0CF-4017-B93C-6AFC5635954FQ35048683-AF4794A6-1723-461F-863D-AC9DB1541483Q35099688-C9426692-DE37-4D2A-8376-1C106475E3D1Q35292347-7BDCF13D-F83D-4292-AA08-115BE81291A0Q35479084-A54B10DA-521A-4798-A7A5-FEFADA8C662BQ35510489-E0465A55-40EB-4A49-9A99-2D08C7D8E326Q35594350-9A30A60D-CDD6-4863-8868-2CC4AF4D4B3AQ35857671-FA5A8F1F-FD46-4DD4-A94F-26857CC74612Q35907425-0957B7B0-511B-47C2-B85A-852C94C6E81BQ35911292-F4F12ECA-530E-4D78-9828-68122141DA15Q35955285-C5DF8665-6E82-4992-9A20-638DBC4625BAQ36082085-7789C5A8-39D2-4E91-9ACA-B1AE924D7DBBQ36239755-0599B756-F4CA-43CB-B69C-2A75064FABC6Q36335774-0413DBE1-BB6C-4E47-8E33-995C6468B2A4
P2860
MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2
description
2010 nî lūn-bûn
@nan
2010 թուականին հրատարակուած գիտական յօդուած
@hyw
2010 թվականին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
MicroRNA-184 inhibits neurobla ...... e serine/threonine kinase AKT2
@ast
MicroRNA-184 inhibits neurobla ...... e serine/threonine kinase AKT2
@en
MicroRNA-184 inhibits neurobla ...... e serine/threonine kinase AKT2
@en-gb
MicroRNA-184 inhibits neurobla ...... e serine/threonine kinase AKT2
@nl
type
label
MicroRNA-184 inhibits neurobla ...... e serine/threonine kinase AKT2
@ast
MicroRNA-184 inhibits neurobla ...... e serine/threonine kinase AKT2
@en
MicroRNA-184 inhibits neurobla ...... e serine/threonine kinase AKT2
@en-gb
MicroRNA-184 inhibits neurobla ...... e serine/threonine kinase AKT2
@nl
prefLabel
MicroRNA-184 inhibits neurobla ...... e serine/threonine kinase AKT2
@ast
MicroRNA-184 inhibits neurobla ...... e serine/threonine kinase AKT2
@en
MicroRNA-184 inhibits neurobla ...... e serine/threonine kinase AKT2
@en-gb
MicroRNA-184 inhibits neurobla ...... e serine/threonine kinase AKT2
@nl
P2093
P2860
P3181
P356
P1433
P1476
MicroRNA-184 inhibits neurobla ...... e serine/threonine kinase AKT2
@en
P2093
Amanda Tivnan
Anne O'Meara
Derek M Murphy
Isabella M Bray
Jacqueline Ryan
Maureen O'Sullivan
Niamh H Foley
Patrick G Buckley
Raymond L Stallings
P2860
P2888
P3181
P356
10.1186/1476-4598-9-83
P407
P577
2010-04-21T00:00:00Z
P5875
P6179
1008806285